Margin of Insight
← Free primer

Investment Memorandum · Preview

For informational purposes only. Not investment advice.

Ingersoll Rand Inc.

IR

FAVORABLE

May 30, 2026

Research Conclusion

At ~$70 (May 2026), Ingersoll Rand trades roughly at probability-weighted fair value (~$67-72). The base case offers ~6% upside; the bull case 40%; the bear case -33%. This makes IR a constructive Hold-to-Modest-Long for quality-tilted industrial portfolios with an 18-36 month horizon, sized at 2-3% of equity book. The thesis is INTACT but requires patience as FY2026 will likely see slower organic execution than FY2027-2028.

Company Overview & Moat Assessment

Ingersoll Rand is a global industrial technology company (~$7.2B revenue, FY2024) that makes mission-critical compressed air, vacuum, pump, and specialty containment products serving manufacturing, semiconductor, life sciences, and infrastructure markets. The company was formed in 2020 when Gardner Denver merged with Ingersoll-Rand's Industrial segment under CEO Vicente Reynal, who has compounded value via the proprietary IRX operating system and a disciplined bolt-on M&A playbook executing 30+ acquisitions without a single goodwill impairment. The business is split between Industrial Technologies & Services (77% of revenue) and Precision & Science Technologies (23%, specialty pumps and pharma containment via ILC Dover and Seepex acquisitions). Roughly 40% of revenue is recurring aftermarket service, providing a meaningful buffer against industrial cyclicality.

▲ Bull Case

  • ◆GLP-1 manufacturing wave drives PST organic growth to +9-10% sustained through 2027-2028, validating the $2.65B ILC Dover thesis and re-rating PST toward IDEX/specialty pump multiples (~17-19x EBITDA).
  • ◆IRX margin expansion accelerates to management's 28-30% guide by FY2027 (one year ahead of schedule); each 100 bps = ~$75M EBITDA / ~$0.15 EPS.
  • ◆Multiple re-rates 2-3 turns toward Atlas Copco as track record extends past 7 years and ROIC clears WACC; ~$98 implied per share (+40% upside).

▼ Bear Case

  • ◆European industrial recession deepens and persists through 2027, with ITS EMEA organic decline of -3-5%; consensus EPS revised down 15-20%.
  • ◆PST/ILC Dover stays stuck at +2-3% organic through 2026 as GLP-1 manufacturing capex slips to 2028+ or is captured by competitors; management forced to admit ILC Dover IRR will land at <10%.
  • ◆Multiple compresses to 12x EV/EBITDA as the IRX margin thesis is questioned; implied ~$47/share (-33% downside).
Primary Debate on Wall Street

“Three debates dominate: (1) Is ILC Dover a strategic success or a $2.65B value-destroying mistake? Verdict: ILC Dover is fair-to-modest IRR (~10-13%) with upside if GLP-1 lifts revenue. (2) Can IR close the EV/EBITDA gap with Atlas Copco? Verdict: partial closure (2-3 turns) likely; full parity unlikely. (3) Is the M&A pipeline sustainable at disciplined valuations? Verdict: bolt-on cadence sustainable; risk is forced overpayment for a transformational deal.”

Top Catalysts
  • ◆ILC Dover / PST revenue recovery (0-12 mo) — GLP-1 fill-finish capacity orders; consensus PST organic growth from 3% to 6%+
  • ◆CHIPS Act semiconductor fab orders (0-18 mo) — Oil-free compressor wins at Intel Ohio, TSMC Arizona, Samsung Texas; $30-60M per major fab
  • ◆European industrial recovery (12-24 mo) — ECB rate cuts + energy normalization drive ITS EMEA from ~0% to +3-5% organic
  • ◆Bolt-on M&A announcements (ongoing) — Each well-priced deal reinforces the M&A compounding narrative
  • ◆EBITDA margin guide raise (each earnings) — Path to 28-30% target
  • ◆Multiple re-rate as ROIC crosses WACC (12-24 mo) — Institutional re-categorization from cyclical to quality compounder
Top Risks
  • ◆Global industrial recession — Aftermarket buffers ~10-12% revenue decline vs. 20-25% for pure equipment makers
  • ◆European industrial weakness — EMEA is 32% of revenue, already in contraction since mid-2022
  • ◆ILC Dover impairment risk — Severe-case scenario contemplates $500-800M write-down if GLP-1 capex disappoints
  • ◆CEO Vicente Reynal departure (key-man risk) — Estimated 10-15% stock impact; no named successor identified
  • ◆FX translation drag — ~55% international revenue; not hedged at translation level
  • ◆Atlas Copco competitive pressure — Long-term market share risk in compressors; competitor scale advantages
  • ◆China deceleration / trade policy — ~10-12% of revenue at risk to tariffs or economic slowdown

Full Memo Continues

5 more sections, locked

  • ●
    Valuation Range & DCF
    Base/bull/bear fair-value range, WACC, terminal growth, sensitivity to revenue + margin assumptions.
  • ●
    Risk/Reward Assessment
    Position-sizing framework with explicit upside/downside skew and entry conditions.
  • ●
    Management & Capital Allocation
    Multi-year capital-allocation track record, incentive alignment, and management readout.
  • ●
    Monitoring Framework
    What to watch each quarter — leading indicators and inflection signals tracked by the analyst.
  • ●
    Unresolved Questions
    Open analyst questions and follow-up research items — the depth signal.

For Agents — $2 per memo

Call the JSON API with a Stripe Shared Payment Token. No account, no signup — just pay and call.

GET /api/v1/research/IR/memo
Authorization: Bearer spt_...

Fund managers — coverage subscriptions launching soon. See marginofinsight.com.

Margin of Insight

For informational purposes only. Not investment advice.